ASSETS

Oncology Pipelines

Pipeline	Indications	Non-clinical			Clinical
		Pharmacology	Toxicology	CMC	P1	P2
MDH-013	Solid cancers, including Colorectal cancer (CRC) Lung cancer (NSCLC) Pancreatic cancer (PC) Hepatobiliary cancer (HBC) Renal & bladder cancer (RBC) Breast & ovary cancer (BOC)	Done	Done	2022 3Q	2024 2Q	2027 1Q
MDH-233	Solid cancers Lymphoma	2023	2025 2Q	2025 2Q	2026 3Q	2029 4Q
MDH-313	Solid cancers Childhood cancers	Done	2024 4Q	2024 4Q	2026 1Q	2028 2Q

Patents